Pcna Marker Detection
Pcna Marker Detection - Related Videos
08:45
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
0 Views •
Cited by 22 •
2017
This study implemented whole genome sequencing for analysis of mutations in genes conferring antifungal drug resistance in Candida glabrata. C. glabrata isolates resistant to echinocandins, azoles and 5-flucytosine, were sequenced to illustrate the methodology. Susceptibility profiles of the isolates correlated with presence or absence of specific mutation patterns in genes.
05:44
The c-FOS Protein Immunohistological Detection: A Useful Tool As a Marker of Central Pathways Involved in Specific Physiological Responses In Vivo and Ex Vivo
0 Views •
Cited by 44 •
2016
Here, we present a protocol based on c-FOS protein immunohistological detection, a classical technique used for the identification of neuronal populations involved in specific physiological responses in vivo and ex vivo.
09:38
Multiplexed Immunofluorescence Assay for Spatial Assessment of Senescence Markers in vivo
0 Views •
2026
Multiplexed immunofluorescence enables sequential labeling of multiple antibody markers within a single tissue section to support spatial analysis of tissue architecture and cell populations. Here, a workflow for multiplex detection of senescence-associated, structural, and immune markers is presented, including manual and automated slide preparation, iterative imaging, and single-cell analysis using digital pathology software.
10:27
A Fast Silver Staining Protocol Enabling Simple and Efficient Detection of SSR Markers using a Non-denaturing Polyacrylamide Gel
0 Views •
Cited by 28 •
2018
Here, we report a simple and low-cost silver staining protocol which requires only three reagents and 7 min of processing, and is suitable for fast generation of high-quality SSR data in the genetic analysis.
08:45
Duplex Digital PCR for Simultaneous Quantification of Dual Genetic Markers
0 Views •
2025
In this video, we demonstrate the duplex digital PCR (ddPCR) technique — a modification of the traditional PCR technique that is useful in detecting two different genetic markers simultaneously. A single PCR reaction is partitioned into nanoliter-sized emulsified droplets that are independently amplified, and the detection of differently colored fluorescence amplification signals from the fraction of droplets is used to compute the initial concentration of the target sequences.
FAQs
PCNA elevation does not by itself prove that a cell is dividing. The protein participates in both DNA replication and DNA repair, so a positive nuclear signal may reflect proliferative activity or a repair response. In neural tissue, this distinction matters when interpreting signals after injury, when repair-related increases could otherwise be mistaken for increased progenitor or glial proliferation.
Interpretation becomes stronger when PCNA distribution is evaluated with additional proliferation markers and cellular context. The surrounding tissue, the identity of the labeled cell, and the experimental condition can help distinguish neural progenitor activity from glial responses or other PCNA-associated activity. This combined approach reduces the risk of assigning every PCNA-positive nucleus to the same biological process.
Because PCNA is a nuclear protein, its detected signal can be related to individual nuclei rather than treated as a nonspecific tissue-wide measurement. Examining where labeled nuclei occur helps researchers describe cellular distributions in neural tissue, while additional markers and context remain necessary to determine whether the signal reflects replication, repair, neural progenitors, or glia.
Fixed tissue and cultured cells are both compatible sample formats. Antibody-based approaches include immunofluorescence, immunohistochemistry, and related assays, allowing researchers to detect PCNA-associated signal in the selected preparation. These formats support analysis of labeled cells in tissue as well as assessment of PCNA expression in cultured cells, depending on the experimental setting.
A workflow begins with a fixed-tissue or cultured-cell preparation, followed by antibody recognition of PCNA and generation of a detectable signal through immunofluorescence, immunohistochemistry, or a related method. Researchers then examine the resulting labeling pattern in relation to the cells and condition studied. Interpretation should retain the DNA-repair caveat rather than treating signal as exclusive evidence of division.
Neuroscience studies can use the resulting pattern to examine changes in neural progenitor activity, adult neurogenesis, or glial proliferation across development, learning, and injury. Comparing these conditions can reveal where PCNA-associated activity changes, but the result should be reported as evidence of PCNA expression or labeling unless complementary markers and cellular context support a more specific proliferation interpretation.